The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease

Thrombosis and Haemostasis

Volumn 82, Issue 3, 1999, Pages 1121-1126

  Gardemann, Andreas ^a,c   Lohre, Jana ^a   Katz, Norbert ^a   Tillmanns, Harald ^a   Hehrlein, Friedrich Wilhelm ^b   Haberbosch, Werner ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

EID: 0032873136     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614340     Document Type: Article

References (34)

1. Hamsten A, Wiman B, De Faire U, Blombäck M. Increased plasma levels of a rapid in hibitor of tissue plasminogen activator in young survivors of myocardial infarction. New Engl J Med 1985; 313: 1557-63.
2. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69:381-7.
3. Hamsten A, de Faire U, Waldius G, Dahlen G, Szamosi A, Landou C, Blombäck M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9.
4. Cortellaro M, Cofrancesco E, Boscheti C. Increased fibrin turnover and high PAI-I activity as predictors of ischemic events in atherosclerotic patients: a case control study. Arterioscler Thromb 1993; 13: 1412-7.
5. Juhan-Vague I, Valadier J, Alessi MC, Allaud MF, Ansaldi J, Philip-Joet C, Halvoet P, Serradimigni A, Collen D. Deficient t-PA release and elevated PA inhibitor in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987; 57: 67-72.
6. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor (PAI-I) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268; 10739-5.
7. Eriksson P, Kallin B, van't Hoofi FM, Bavenholm P, Hamsten P, Allele-specific increase in basal transcription of the plasminogen-activator inhibitor I gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995; 92: 1851-5.
8. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney AM, Cambien F. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhihitor-I (PAI-I) gene is associated with differences in plasma PAI-I activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 1995; 74: 837-41.
9. Dawson S, Hamsten A, Wiman B. Henney A. Humphries SE. Genetic variation at the plasminogen activator inhibitor-I locus is associated with altered levels of plasminogen activator inhihitor-I activity. Artcrioscler Thromb 1991; 11: 183-90.
10. Mansfield MW. Stickland MH. Grant PJ. Plasminogen activator-I (PAI-I) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995:74: 1032-4.
11. ll.Ossei-Gerning N. Mansfield MW, Stickland MH, Wilson IJ, Grant PJ. Plasminogen activator inhibitor-I promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary argiography. Arterioscler Thromb Vasc Biol 1997; 17:33-7.
12. Colaizzo D, Margaglione M, Lirato C, Grandone E, Cappucci G, Fischetti A, Mancini FP, Pauciullo P, Di Minno G. Plasminogen activator inhibitor I 4G/5G in subjects with a history of juvenile coronary heart disease. Thromb Haemost 1997; Suppl: 97 (Abstract).
13. Van der Boom JC, Bots ML, Slagboom PE, Haverkate F, Meijer P, Kluft C, Grobbee DE. The risk of smoking is modified by the 4G allele of the PAI-I gene. Thromb Haemost 1997; Suppl: 579 (Abstract).
14. Margaglione M, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, Grandone E, Pennelli O, Di Minno G. The PAI-I gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vase Biol 1998; 18: 152-6.
15. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 1997; 95:59-62.
16. Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Donati MB, Iacoviello L. 4G/5G polymorphism in the promoter region of the PAI-I gene is not a risk factor for familial myocardial infarction: a case-control study in a sample of GISSI-2 patients. Thromb Haemost 1997; 78: 1294-5.
17. Sugano T, Tsuji H, Masuda H, Nakagawa K, Nishimura K, Kasahara T Yoshizumi T, Nakahara Y, Kitamura H, Yamada K, Yoneda M, Maki K, Tatsumi T, Azuma A, Nakagawa M. Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population. Blood Coagulation and Fibrinolysis 1998; 9: 201-4.
18. Junker R, Heinrich J, Schulte H, Tataru M, Kohler E, Schonfield R, Nowak Gottl U, Assmann G. Plasminogen activator inhibtor-1 4G/5G polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. Blood Coagulation and Fibrinolysis 1998; 9: 597-602.
19. Iacoviello L, Burzotta F, Di Castelnuovo A, Zito F, Marchioli R, Donati MB. The 4G/5G polymorphism of PAI-I promoter gene and the risk of myocardial infarction: A meta-analysis. Thromb Haemost 1998; 80: 1029-30.
20. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
21. Gardemann A, Fink M, Stricker J, Nguyen Q, Humme J, Katz N, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W. ACE I/D gene polymorphism: Presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis, 1998; 139:153-9.
22. Margaglione M, Grandone E, Cappucci G, Colaizzo D, Giulani N, Vecchione G, d'Addedda M, Di Minno. An alternative method for PAI-I promoter (4G/5G) typing. Thromb Haemost 1997; 605-6.
23. Philips M, Juul AG, Thorsen S. Human endothelial cells produce a plasminogen activator inhibitor complex. Biochem Biophys Acta 1984; 802: 99-110.
24. Simpson AJ, Booth NA, Moore NR, Benneth B. Distribution of PAI-I in tissue. J Clin Pathol 1991; 44: 139-43.
25. Kruithof EKO, Trans-Thang C, Bachman F. Studies on the release of PAI-I from human platelets. Thromb Haemost 1987; 55; 201-5.
26. Booth NA, Simpson AJ, Croll A, Bennet B, Mac Gregor IR. PAI-I in plasma and platelets. Brit J Haematol 1988; 70: 327-33.
27. Heaton JH, Nebes VL, O'Dell LG, Morris SM Jr, Gelehrter TD. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol 1989; 3: 185-92.
28. Heaton JH, Gelehrter TD. Glucocorticoid induction of plasminogen activator and plasminogen activator inhibitor messenger RNA in rat hepatoma cells. Mol Endocrinol 1989; 3: 349-55.
29. Nordt TK, Sawa H, Fujii S, Sobel BE. Induction of plasminogen activator inhibitor type-1 by proinsulin and insulin in vivo. Circulation 1995; 91: 764-70.
30. De Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem S, Voorn GP, Lambers JWJ, van Mourik JA, Hack CE. PAI-I synthesis in the human hepatoma cell line hep G2 is increased by cytokines - evidence that the liver contributes to acute phase behaviour of PAI-I. Thromb Haemost 1999; 65: 181-5.
31. Dichek D, Quertermous T. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. Blood 1989; 74: 222-8.
32. Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells. J Clin Invest 1986; 78: 1673-80.
33. Riccio A, Lund LR, Sartorio R, Lania A, Anderasen PA, Dano K Blasi F. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-I) gene. Nucleic Acids Res 1988; 16: 2805-24.
34. 807T gene polymorphism with myocardial infarction in younger patients. Blood 1999; 93: 2449-53.